Does Ursodeoxycholic Acid Change the Proliferation of the Colorectal Mucosa?
Authors:
- Thomas OchsenkühnTOThomas Ochsenkühn
- Igor MarstellerIMIgor Marsteller
- Ulrich HayUHUlrich Hay
- Joachim DieboldJDJoachim Diebold
- Gustav PaumgartnerGPGustav Paumgartner
- Burkhard GökeBGBurkhard Göke
- Michael SackmannMSMichael Sackmann
- 1 April 2003
- journal article
- clinical trial
- Published by S. Karger AG in Digestion
- Vol. 68 (4) , 209-216
Abstract
Background: In animal models ursodeoxycholic acid (UDCA) showed a chemoprotective effect against colon cancer. To explain this, a reduced proliferation of the colorectal mucosal proliferation was suggested. We, therefore, examined the influence of UDCA on the proliferation of normal colorectal mucosa in humans. Methods: Following endoscopic polypectomy, 20 patients with colorectal adenomas were randomized to receive either UDCA (750 mg/day, n = 10, group A) or placebo (n = 10, group B) for 6 months in a double-blinded way. Colorectal biopsies were sampled before and at the end of the medication by total colonoscopy. Colorectal mucosal proliferation was measured by FACScan analysis of propidium iodine labeling. Serum was sampled, and serum bile acids were analyzed by gas chromatography. Results: The proliferation rates at the end of the study were similar in both groups (median 15.4%; range 12.0–20.9 in group A; median 16.0%, 14.0–20.2 in group B, p = 0.41). Serum lithocholic acid levels at the end of the study were significantly higher in group A (1.3 µmol/l, 0.9–1.8) than in group B (0.7 µmol/l, 0–1.7, p < 0.02), whereas serum deoxycholic acid levels were similar in both groups. Conclusions: In this study, UDCA treatment for 6 months does not seem to induce changes in the proliferative behavior of the colorectal mucosa in patients with adenomas. It seems likely that a putative chemopreventive effect of UDCA in humans is not exerted by a reduction of the colorectal proliferation.Keywords
This publication has 23 references indexed in Scilit:
- Ursodeoxycholic Acid Therapy and the Risk of Colorectal Adenoma in Patients With Primary Biliary Cirrhosis: An Observational StudyHepatology, 2003
- A role for apoptosis in the control of neutrophil homeostasis in the circulation: insights from CD18-deficient miceBlood, 2003
- Chemoprevention of Colorectal CancerNew England Journal of Medicine, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Plasma deoxycholic acid is related to deoxycholic acid in faecal waterCancer Letters, 1997
- Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential*1Hepatology, 1995
- A genetic model for colorectal tumorigenesisCell, 1990
- Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancerCancer Letters, 1988
- Diagnostic sensitivity of fasting and postprandial serum bile acids determined by different methodsClinica Chimica Acta, 1987
- Determination of bile acids in serum by capillary gas-liquid chromatographyClinica Chimica Acta, 1979